Search

Your search keyword '"Gornet, Jean-Marc"' showing total 367 results

Search Constraints

Start Over You searched for: "Gornet, Jean-Marc" Remove constraint "Gornet, Jean-Marc"
367 results on '"Gornet, Jean-Marc"'

Search Results

1. Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases

2. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

4. Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study

6. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

7. Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

9. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID

10. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study

11. Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus

12. Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)

13. Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative

14. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group

15. Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study

16. Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα Resumption

17. Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease

20. Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study

21. High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease

22. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

23. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

24. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

27. Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

29. Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial

31. Autologous organoid co-culture model reveals T cell-driven epithelial cell death in Crohn’s Disease

32. Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?

33. Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID

34. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID

36. Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort

37. Efficacy of adalimumab in patients with Crohnʼs disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

38. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

39. Associations between the severity of medical and surgical complications and perception of surgeon empathy in esophageal and gastric cancer patients

49. A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease

Catalog

Books, media, physical & digital resources